CHEVRON CORP (CVX)

US1667641005 - Common Stock

163.57  +0.72 (+0.44%)

After market: 163.61 +0.04 (+0.02%)

Fundamental Rating

4

Overall CVX gets a fundamental rating of 4 out of 10. We evaluated CVX against 214 industry peers in the Oil, Gas & Consumable Fuels industry. CVX is in great health and has no worries on liquidiy or solvency at all, but the profibility rating is only average. CVX is valued expensive and it does not seem to be growing. CVX also has an excellent dividend rating.



4

1. Profitability

1.1 Basic Checks

In the past year CVX was profitable.
CVX had a positive operating cash flow in the past year.
Of the past 5 years CVX 4 years were profitable.
In the past 5 years CVX always reported a positive cash flow from operatings.

1.2 Ratios

With a Return On Assets value of 8.17%, CVX perfoms like the industry average, outperforming 57.75% of the companies in the same industry.
CVX's Return On Equity of 13.28% is in line compared to the rest of the industry. CVX outperforms 46.01% of its industry peers.
The Return On Invested Capital of CVX (7.88%) is comparable to the rest of the industry.
The Average Return On Invested Capital over the past 3 years for CVX is significantly below the industry average of 45.80%.
Industry RankSector Rank
ROA 8.17%
ROE 13.28%
ROIC 7.88%
ROA(3y)9.48%
ROA(5y)5.47%
ROE(3y)15.59%
ROE(5y)8.92%
ROIC(3y)9.08%
ROIC(5y)N/A

1.3 Margins

CVX has a Profit Margin (10.85%) which is in line with its industry peers.
In the last couple of years the Profit Margin of CVX has grown nicely.
The Operating Margin of CVX (12.76%) is worse than 66.20% of its industry peers.
CVX's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 39.47%, CVX is in line with its industry, outperforming 45.07% of the companies in the same industry.
CVX's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.76%
PM (TTM) 10.85%
GM 39.47%
OM growth 3YN/A
OM growth 5Y5.57%
PM growth 3YN/A
PM growth 5Y3.05%
GM growth 3Y-5.36%
GM growth 5Y-0.49%

7

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so CVX is still creating some value.
Compared to 1 year ago, CVX has less shares outstanding
The number of shares outstanding for CVX has been reduced compared to 5 years ago.
CVX has a better debt/assets ratio than last year.

2.2 Solvency

CVX has an Altman-Z score of 3.97. This indicates that CVX is financially healthy and has little risk of bankruptcy at the moment.
CVX's Altman-Z score of 3.97 is amongst the best of the industry. CVX outperforms 82.63% of its industry peers.
CVX has a debt to FCF ratio of 1.05. This is a very positive value and a sign of high solvency as it would only need 1.05 years to pay back of all of its debts.
CVX's Debt to FCF ratio of 1.05 is amongst the best of the industry. CVX outperforms 83.57% of its industry peers.
A Debt/Equity ratio of 0.13 indicates that CVX is not too dependend on debt financing.
CVX has a Debt to Equity ratio of 0.13. This is in the better half of the industry: CVX outperforms 77.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF 1.05
Altman-Z 3.97
ROIC/WACC0.9
WACC8.72%

2.3 Liquidity

CVX has a Current Ratio of 1.27. This is a normal value and indicates that CVX is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.27, CVX perfoms like the industry average, outperforming 54.93% of the companies in the same industry.
CVX has a Quick Ratio of 1.01. This is a normal value and indicates that CVX is financially healthy and should not expect problems in meeting its short term obligations.
CVX has a Quick ratio of 1.01. This is comparable to the rest of the industry: CVX outperforms 50.23% of its industry peers.
Industry RankSector Rank
Current Ratio 1.27
Quick Ratio 1.01

1

3. Growth

3.1 Past

The earnings per share for CVX have decreased strongly by -30.27% in the last year.
The Earnings Per Share has been growing by 11.15% on average over the past years. This is quite good.
CVX shows a very negative growth in Revenue. In the last year, the Revenue has decreased by -16.46%.
The Revenue has been growing slightly by 4.40% on average over the past years.
EPS 1Y (TTM)-30.27%
EPS 3YN/A
EPS 5Y11.15%
EPS growth Q2Q-15.65%
Revenue 1Y (TTM)-16.46%
Revenue growth 3Y27.74%
Revenue growth 5Y4.4%
Revenue growth Q2Q-10.25%

3.2 Future

The Earnings Per Share is expected to decrease by -5.30% on average over the next years.
The Revenue is expected to decrease by -5.90% on average over the next years.
EPS Next Y-2.49%
EPS Next 2Y5.27%
EPS Next 3Y3.2%
EPS Next 5Y-5.3%
Revenue Next Year-3.44%
Revenue Next 2Y-1.5%
Revenue Next 3Y-1.71%
Revenue Next 5Y-5.9%

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.

3

4. Valuation

4.1 Price/Earnings Ratio

CVX is valuated correctly with a Price/Earnings ratio of 12.46.
The rest of the industry has a similar Price/Earnings ratio as CVX.
CVX is valuated cheaply when we compare the Price/Earnings ratio to 25.25, which is the current average of the S&P500 Index.
Based on the Price/Forward Earnings ratio of 12.78, the valuation of CVX can be described as correct.
CVX's Price/Forward Earnings ratio is in line with the industry average.
The average S&P500 Price/Forward Earnings ratio is at 21.67. CVX is valued slightly cheaper when compared to this.
Industry RankSector Rank
PE 12.46
Fwd PE 12.78

4.2 Price Multiples

CVX's Enterprise Value to EBITDA ratio is in line with the industry average.
The rest of the industry has a similar Price/Free Cash Flow ratio as CVX.
Industry RankSector Rank
P/FCF 15.28
EV/EBITDA 7.37

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.12
EPS Next 2Y5.27%
EPS Next 3Y3.2%

8

5. Dividend

5.1 Amount

CVX has a Yearly Dividend Yield of 4.14%, which is a nice return.
Compared to an average industry Dividend Yield of 5.79, CVX pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 2.45, CVX pays a better dividend.
Industry RankSector Rank
Dividend Yield 4.14%

5.2 History

The dividend of CVX is nicely growing with an annual growth rate of 6.07%!
CVX has paid a dividend for at least 10 years, which is a reliable track record.
CVX has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.07%
Div Incr Years18
Div Non Decr Years18

5.3 Sustainability

CVX pays out 53.05% of its income as dividend. This is a bit on the high side, but may be sustainable.
CVX's earnings are declining while the Dividend Rate has been growing. This means the dividend growth is most likely not sustainable.
DP53.05%
EPS Next 2Y5.27%
EPS Next 3Y3.2%

CHEVRON CORP

NYSE:CVX (4/24/2024, 7:04:00 PM)

After market: 163.61 +0.04 (+0.02%)

163.57

+0.72 (+0.44%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)
Earnings (Next)
Inst Owners
Inst Owner Change
Ins Owners
Ins Owner Change
Market Cap302.17B
Analysts
Price Target
Dividend
Industry RankSector Rank
Dividend Yield 4.14%
Dividend Growth(5Y)
DP
Div Incr Years
Div Non Decr Years
Ex-Date
Surprises & Revisions
EPS beat(2)
Avg EPS beat(2)
Min EPS beat(2)
Max EPS beat(2)
EPS beat(4)
Avg EPS beat(4)
Min EPS beat(4)
Max EPS beat(4)
EPS beat(8)
Avg EPS beat(8)
EPS beat(12)
Avg EPS beat(12)
EPS beat(16)
Avg EPS beat(16)
Revenue beat(2)
Avg Revenue beat(2)
Min Revenue beat(2)
Max Revenue beat(2)
Revenue beat(4)
Avg Revenue beat(4)
Min Revenue beat(4)
Max Revenue beat(4)
Revenue beat(8)
Avg Revenue beat(8)
Revenue beat(12)
Avg Revenue beat(12)
Revenue beat(16)
Avg Revenue beat(16)
PT rev (1m)
PT rev (3m)
EPS NQ rev (1m)
EPS NQ rev (3m)
EPS NY rev (1m)
EPS NY rev (3m)
Revenue NQ rev (1m)
Revenue NQ rev (3m)
Revenue NY rev (1m)
Revenue NY rev (3m)
Valuation
Industry RankSector Rank
PE 12.46
Fwd PE 12.78
P/S
P/FCF
P/OCF
P/B
P/tB
EV/EBITDA
EPS(TTM)
EY
EPS(NY)
Fwd EY
FCF(TTM)
FCFY
OCF(TTM)
OCFY
SpS
BVpS
TBVpS
PEG (NY)N/A
PEG (5Y)1.12
Profitability
Industry RankSector Rank
ROA 8.17%
ROE 13.28%
ROCE
ROIC
ROICexc
ROICexgc
OM 12.76%
PM (TTM) 10.85%
GM 39.47%
FCFM
ROA(3y)
ROA(5y)
ROE(3y)
ROE(5y)
ROIC(3y)
ROIC(5y)
ROICexc(3y)
ROICexc(5y)
ROICexgc(3y)
ROICexgc(5y)
ROCE(3y)
ROCE(5y)
ROICexcg growth 3Y
ROICexcg growth 5Y
ROICexc growth 3Y
ROICexc growth 5Y
OM growth 3Y
OM growth 5Y
PM growth 3Y
PM growth 5Y
GM growth 3Y
GM growth 5Y
F-Score
Asset Turnover0.75
Health
Industry RankSector Rank
Debt/Equity 0.13
Debt/FCF
Debt/EBITDA
Cap/Depr
Cap/Sales
Interest Coverage
Cash Conversion
Profit Quality
Current Ratio 1.27
Quick Ratio 1.01
Altman-Z
F-Score
WACC
ROIC/WACC
Cap/Depr(3y)
Cap/Depr(5y)
Cap/Sales(3y)
Cap/Sales(5y)
Profit Quality(3y)
Profit Quality(5y)
Growth
EPS 1Y (TTM)-30.27%
EPS 3YN/A
EPS 5Y
EPS growth Q2Q
EPS Next Y-2.49%
EPS Next 2Y
EPS Next 3Y
EPS Next 5Y
Revenue 1Y (TTM)-16.46%
Revenue growth 3Y27.74%
Revenue growth 5Y
Revenue growth Q2Q
Revenue Next Year
Revenue Next 2Y
Revenue Next 3Y
Revenue Next 5Y
EBIT growth 1Y
EBIT growth 3Y
EBIT growth 5Y
EBIT Next Year
EBIT Next 3Y
EBIT Next 5Y
FCF growth 1Y
FCF growth 3Y
FCF growth 5Y
OCF growth 1Y
OCF growth 3Y
OCF growth 5Y